Rastyteln e ekstrakt | tadimax tablets coated. captivity. about. 42 pcs.

Release form

Film-coated tablets

Packing

42 pcs.

Pharmacological action

Pharmacotherapeutic group: Treatment for benign prostatic hyperplasia of plant origin.

Pharmacological properties: The drug has anti-inflammatory, analgesic, moderate angioprotective effect.

Indications

In complex therapy to eliminate dysuric disorders, with benign prostatic hyperplasia of the I and II stages.

Contraindications

Hypersensitivity to the drug, severe hepatic impairment.

Special instructions

It is recommended that you consult a doctor before use.

Composition

Active substances: 371.3 mg of a thick aqueous extract (14.5: 1) from a mixture: Krinum leaves 2 g, Rhizomes of rhizomes 0.666 g, Velvet bark 0.666 g, Motherwort herb 0.666 g, Peach seed 0.083 g, Alismatis rhizome 0.830 g, Peony root 0.500 g, Cinnamon bark 0.0083 g

excipients: colloidal silicon dioxide, starch, magnesium sgearate, hypromellose, talc, titanium dioxide macrogol 6000, red iron oxide (E 172), black iron oxide (E 172).

Dosage and administration

Inside, 2 tablets 3 times a day after meals. The drug should be taken according to the following scheme: 3 courses of 7 days of admission with breaks between courses of 7 days. The duration of treatment is determined by the doctor.

Side effects

Allergic reactions possible. In 5% of cases, at the beginning of the use of the drug, patients may experience a burning sensation in the anus. This phenomenon occurs during the administration of the drug.

Storage conditions

In a dry, dark place at a temperature of 15 to 25 РC

Keep out of the reach of children!

Expiration

3 years.

Deystvuyuschee substances

Rastyteln e extracts

dosage form

tablets